Statin use is associated with a lower risk of recurrence after curative resection in BCLC stage 0-A hepatocellular carcinoma

Yang S.-Y.Wang C.-C.Chen K.-D.Liu Y.-W.Lin C.-C.Chuang C.-H.Yu-Chieh TsaiYao C.-C.Yen Y.-H.Hsiao C.-C.Hu T.-H.Tsai M.-C.2022-05-232022-05-2320211471-2407https://www.scopus.com/inward/record.uri?eid=2-s2.0-85099379614&doi=10.1186%2fs12885-021-07796-7&partnerID=40&md5=8bb875be83cd24c0870f575de6f251bahttps://scholars.lib.ntu.edu.tw/handle/123456789/611404Statin use is associated with a lower risk of recurrence after curative resection in BCLC stage 0-A hepatocellular carcinomajournal article10.1186/s12885-021-07796-7334461272-s2.0-85099379614